Tower Research Capital LLC (Trc) Vallon Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.22 - $0.52 $25 - $59	-114 Reduced 0.95%	11,907 $3,000
Q3 2022 Nov 10, 2022	SELL	$0.3 - $0.68 $5 - $12	-19 Reduced 0.16%	12,021 $3,000
Q2 2022 Aug 15, 2022	SELL	$0.42 - $2.27 $1,422 - $7,688	-3,387 Reduced 21.96%	12,040 $8,000
Q1 2022 May 12, 2022	BUY	$1.79 - $8.0 $25,690 - $114,816	14,352 Added 1335.07%	15,427 $29,000
Q4 2021 Feb 14, 2022	BUY	$4.02 - $7.3 $4,321 - $7,847	1,075 New	1,075 $6,000
Q3 2021 Nov 15, 2021	SELL	$3.85 - $9.68 $65 - $164	-17 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.66 - $5.83 $62 - $99	17 New	17 $0

Ticker VLON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,512,800
Description
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.